INTERNATIONAL PATENT: JANSSEN BIOTECH, INC. FILES APPLICATION FOR "ENPP3 x CD3 BISPECIFIC ANTIBODIES AND USE THEREOF"

GENEVA, June 23 -- JANSSEN BIOTECH, INC. (800/850 Ridgeview DriveHorsham, Pennsylvania 19044) filed a patent application (PCT/IB2024/062563) for "ENPP3 x CD3 BISPECIFIC ANTIBODIES AND USE THEREOF" on Dec 12, 2024. With publication no. WO/2025/126102, the details related to the patent application was published on Jun 19, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): THORNTON, Katherine (920 US Route 202P.O. Box 300Raritan, New Jersey 08869), KALOTA, Anna (920 US Route 202P.O. Box 300Raritan, New Jersey 08869)

Abstract: The present disclosure provides ENPP3 binding agents, including bispe...